This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Dental Faces Regulatory Challenges: Only 5 Stocks to Pick
by Zacks Equity Research
Owing to the adversities in the medical universe, market watchers have adopted a bearish stance toward the dental space. These are the only five dental stocks that are expected to beat the ongoing MedTech gloom.
AbbVie Inc. (ABBV) in Focus: Stock Moves 6.1% Higher
by Zacks Equity Research
AbbVie (ABBV) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away?
by Zacks Equity Research
Aceto Corporation (ACET) has witnessed a significant price decline in the past four weeks, and has seen negative earnings estimate revisions for the current quarter and year.
Merit Medical Systems (MMSI) Worth a Look: Stock Gains 7.7%
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) shares rose almost 8% in the last trading session.
Merit Medical Embosphere Gets FDA de novo Classification
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) recently announced the receipt of 513(f)(2) (de novo) classification for Embosphere Microspheres from the FDA to expand its indication in the prostatic artery embolization (PAE) space.
Merit Medical (MMSI) Closes 5.2M Follow-On Share Offering
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) announced that it has closed its follow-on public offering of 5.2 million shares of common stock at $28.25 per share.
Top Ranked Momentum Stocks to Buy for March 30th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th:
Merit Medical (MMSI) Prices 4.5M Follow-On Share Offering
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) announced that it has priced its follow-on public offering of 4.5 million shares of common stock at $28.25 per share.
Merit Medical (MMSI) to Refinance Debt via Share Offering
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) announced that it has commenced a follow on public offering of its common stock.
MedTech Stocks Earnings Slated on Feb 21: MDT, HSIC and More
by Zacks Equity Research
Let's take a look at the major MedTech stocks slated to release their Oct-Dec 2016 numbers on Feb 21.
Merit Medical Hits 52-Week High: What's Driving the Stock?
by Zacks Equity Research
Share price of South Jordan, Utah-based Merit Medical Systems, Inc. (MMSI) reached a fresh 52-week high of $26.80 on Dec 9, finally closing a tad lower at $26.60.